OConnor, Richard D.; Nelson, Harold; Borker, Rohit; … - In: PharmacoEconomics 22 (2004) 12, pp. 815-825
Background: Asthma is a chronic disease, the two main components of which are inflammation and bronchoconstriction. Fluticasone propionate (FP) and salmeterol, a strategy that treats both main components of asthma, has been recently compared with FP plus montelukast in a randomised clinical...